Physician profile
Charles Scott Needham
NPI 1063435899
$18,373.71
in general payments reported to CMS, 2019-2025
23 companies · $5,531 in 2025
The $5,531 reported for 2025 was more than what 84% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,212 · 2020: $2,108 · 2021: $500 · 2022: $103 · 2023: $1,012 · 2024: $909 · 2025: $5,531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $4,111 · Food and Beverage: $2,198 · Travel and Lodging: $1,143.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $4,111.11 |
| Food and Beverage | $2,197.75 |
| Travel and Lodging | $1,142.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $4,867.45 | 2019-2024 | Gore Viabahn Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Angiodynamics, INC. | $4,770.77 | 2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac |
| Medtronic Vascular, INC. | $3,175.97 | 2019-2020 | |
| Penumbra, INC. | $2,412.15 | 2019-2020 | |
| Medtronic, INC. | $1,623.41 | 2022-2025 | Venaseal, Penditure |
| Edwards Lifesciences Corporation | $386.50 | 2019-2025 | Sapien 3 Ultra Resilia |
| Kls-Martin L.P. | $197.70 | 2025 | |
| Merit Medical Systems INC | $161.96 | 2021 | |
| Abbott Laboratories | $147.67 | 2021-2023 | Jot Dx |
| Bolton Medical INC | $110.95 | 2025 | Gelweave, Thoraflex Hybrid |
| Atricure, INC. | $92.64 | 2025 | Synergy Ablation System |
| Baxter Healthcare | $75.40 | 2025 | Floseal |
| Philips North America LLC | $60.15 | 2023 | |
| Quest Medical INC. | $49.98 | 2019 | |
| Boston Scientific Corporation | $45.63 | 2020-2025 | Watchman Flx |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $44.01 | 2019-2020 | |
| Haemonetics Corporation | $42.54 | 2025 | Teg6s Hemostasis System |
| Nevro Corp. | $33.07 | 2022 | |
| Cardiovascular Systems INC. | $20.36 | 2021 | |
| Amgen INC. | $16.61 | 2020 | |
| Janssen Pharmaceuticals, INC | $14.60 | 2022 | |
| Amarin Pharma, INC. | $12.17 | 2020 | |
| Terumo Medical Corporation | $12.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Needham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.